Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in Fallopian tube carcinoma

Abstract

Fallopian tube carcinoma (FTC) is a rare, poorly studied and aggressive cancer, associated with poor survival. Since tumorigenesis is related to the acquisition of genetic changes, we used genome-wide array comparative genomic hybridization to analyse copy number aberrations occurring in FTC in order to obtain a better understanding of FTC carcinogenesis and to identify prognostic events and targets for therapy. We used arrays of 2464 genomic clones, providing 1.4 Mb resolution across the genome to map genomic DNA copy number aberrations quantitatively from 14 FTC onto the human genome sequence. All tumors showed a high frequency of copy number aberrations with recurrent gains on 3q, 6p, 7q, 8q, 12p, 17q, 19 and 20q, and losses involving chromosomes 4, 5q, 8p, 16q, 17p, 18q and X. Recurrent regions of amplification included 1p34, 8p11–q11, 8q24, 12p, 17p13, 17q12–q21, 19p13, 19q12–q13 and 19q13. Candidate, known oncogenes mapping to these amplicons included CMYC (8q24), CCNE1 (19q12–q21) and AKT2 (19q13), whereas PIK3CA and KRAS, previously suggested to be candidate driver genes for amplification, mapped outside copy number maxima on 3q and 12p, respectively. The FTC were remarkably homogeneous, with some recurrent aberrations occurring in more than 70% of samples, which suggests a stereotyped pattern of tumor evolution.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T and Tahara E . (1995). Jpn. J. Cancer Res., 86, 617–621.

  • Aziz S, Kuperstein G, Rosen B, Cole D, Nedelcu R, McLaughlin J and Narod SA . (2001). Gynecol. Oncol., 80, 341–345.

  • Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo W-L, Gray JW and Pinkel D . (2000). Nat. Genet., 25, 144–146.

  • Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Benedetti Panici P, Mancuso S, Neri G and Testa JR . (1995). Int. J. Cancer, 64, 280–285.

  • Caduff RF, Svoboda-Newman SM, Bartos RE, Ferguson AW and Frank TS . (1998). Am. J. Surg. Pathol., 22, 319–326.

  • Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN and Testa JR . (1992). Proc. Natl. Acad. Sci. USA, 89, 9267–9271.

  • Cheung VG, Nowak N, Jang W, Kirsch IR, Zhao S, Chen XN, Furey TS, Kim UJ, Kuo WL, Olivier M, Conroy J, Kasprzyk A, Massa H, Yonescu R, Sait S, Thoreen C, Snijders A, Lemyre E, Bailey JA, Bruzel A, Burrill WD, Clegg SM, Collins S, Dhami P, Friedman C, Han CS, Herrick S, Lee J, Ligon AH, Lowry S, Morley M, Narasimhan S, Osoegawa K, Peng Z, Plajzer-Frick I, Quade BJ, Scott D, Sirotkin K, Thorpe AA, Gray JW, Hudson J, Pinkel D, Ried T, Rowen L, Shen-Ong GL, Strausberg RL, Birney E, Callen DF, Cheng JF, Cox DR, Doggett NA, Carter NP, Eichler EE, Haussler D, Korenberg JR, Morton CC, Albertson D, Schuler G, de Jong PJ, Trask BJ . (2001). Nature, 409, 953–958.

  • Chung TK, Cheung TH, To KF and Wong YF . (2000). Gynecol. Obstet. Invest., 49, 47–51.

  • Dutrillaux B, Muleris M and Seureau MG . (1986). Int. J. Cancer, 38, 475–479.

  • Geisen C and Möröy T . (2002). J. Biol. Chem., 277, 39909–39918.

  • Haas K, Johannes C, Geisen C, Schmidt T, Karsunky H, Blass-Kampmann S, Obe G and Möryö T . (1997). Oncogene, 15, 2615–2623.

  • Hellström A-C, Hue J, Silfverswärd C and Auer G . (1994). Int. J. Gynecol. Cancer, 4, 408–413.

  • Heselmeyer K, Hellström A-C, Blegen H, Schröck E, Silfverswärd C, Shah K, Auer G and Ried T . (1998). Int. J. Gynecol. Pathol., 17, 245–254.

  • Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D . (1994). Genes Chromosomes Cancer, 10, 231–243.

  • Karhu R, Kähkönen M, Kuukasjärvi T, Pennanen S, Tirkkonen M and Kallioniemi O . (1997). Cytometry, 28, 198–205.

  • Kitahara K, Yasui W, Kuniyasu H, Yokozaki H, Akama Y, Yunotani S, Hisatsugu T and Tahara E . (1995). Int. J. Cancer, 62, 25–28.

  • Knight SJ, Lese CM, Precht KS, Kuc J, Ning Y, Lucas S, Regan R, Brenan M, Nicod A, Lawrie NM, Cardy DL, Nguyen H, Hudson TJ, Riethman HC, Ledbetter DH and Flint J . (2000). Am. J. Hum. Genet., 67, 320–332.

  • Jain AN, Tokuyasu T, Snijders AM, Segraves R, Albertson DG and Pinkel D . (2002). Genome Res., 12, 325–332.

  • Leeper K, Garcia R, Swisher E, Goff B, Greer B and Paley P . (2002). Gynecol. Oncol., 87, 52–56.

  • Lin L, Prescott MS, Zhu Z, Singh P, Chun SY, Kuick RD, Hanash SM, Orringer MB, Glover TW and Beer DG . (2000). Cancer Res., 60, 7021–7027.

  • Manavi M, Berger A, Kucera E, Schneeweiss A, Kucera H, Kubista E and Czerwenka K . (1998). Gynecol. Oncol., 71, 165–171.

  • Marone M, Scambia G, Giannitelli C, Ferrandina G, Masciullo V, Bellacosa A, Benedetti-Panici P and Mancuso S . (1998). Int. J. Cancer, 75, 34–39.

  • Mizuuchi M, Mori Y, Sato K, Kamiya H, Okamura N, Nasim S, Garrett CT and Kudo R . (1995). Cancer, 76, 86–90.

  • Monk BJ, Chapman JA, Johnson GA, Brightman BK, Wilczynski SP, Schell MJ and Fan H . (1994). Am. J. Obstet. Gynecol., 171, 1193–1198.

  • Pere J, Tapper J, Seppälä M, Knuutila S and Butzow R . (1998). Cancer Res., 58, 4274–4276.

  • Piek JMM, van Diest PJ, Zweemer RR, Jansen JW, Poort-Keesom RJJ, Menko FH, Gille JJP, Jongsma APM, Pals G, Kenemans P and Verheijen RHM . (2001). J. Pathol., 195, 451–456.

  • Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo W-L, Chen C, Zhai Y, Dairkee SH, Ljung B-M, Gray JW and Albertson DG . (1998). Nat. Genet., 20, 207–211.

  • Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D and Brown PO . (1999). Nat. Genet., 23, 41–46.

  • Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP and Sauter G . (2000). Am. J. Pathol., 157, 787–794.

  • Snijders AM, Fridlyand J, Mans DA, Segraves R, Jain AN, Pinkel D and Albertson DG . (2003). Oncogene, in press.

  • Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D and Albertson DG . (2001). Nat. Genet., 29, 263–264.

  • Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T and Lichter P . (1997). Cancer Res., 56, 3803–3807.

  • Spruck CH, Won K-A and Reed S . (1999). Nature, 401, 297–300.

  • Sun PC, Uppaluri R, Schmidt AP, Pashia ME, Quant EC, Sunwoo JB, Gollin SM and Scholnick SB . (2001). Genomics, 75, 17–25.

  • Wang ZR, Liu W, Smith ST, Parrish RS and Young SR . (1999). Exp. Mol. Pathol., 66, 140–148.

  • Weiss MM, Hermsen MAJA, Meijer GA, van Grieken NCT, Baak JPA, Kuipers EJ and van Diest PJ . (1999). J. Clin. Pathol. – Mol. Pathol., 52, 243–251.

  • Yuan ZQ, Sun M, Feldman RI, Wang G, Ma X, Chen J, Coppola D, Nicosia SV and Cheng JQ . (2000). Oncogene, 19, 2324–2330.

  • Zweemer RP, Ryan A, Snijders AM, Hermsen MA, Meijer GA, Beller U, Menko FH, Jacobs IJ, Baak JP, Verheijen RH, Kenemans P and van Dienst PJ . (2001). Lab. Invest., 81, 1363–1370.

  • Zweemer RP, van Diest PJ, Verheijen RHM, Ryan A, Gille JJP, Sijmons RH, Jacobs IJ, Menko FH and Kenemans P . (2000). Gynecol. Oncol., 76, 45–50.

Download references

Acknowledgements

We thank S Blackwood, N Brown, G Hamilton, B Huey, S Kwek, A Matthäi and R Segraves for their participation in discussions and array production, and K Kimura and the UCSF Cancer Center Bioinformatics Core for microarray database support. This work was supported by NIH Grants CA94407 and CA83040, by Grant 901-02-241 from NOW and by a grant from the Biocare Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donna G Albertson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Snijders, A., Nowee, M., Fridlyand, J. et al. Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in Fallopian tube carcinoma. Oncogene 22, 4281–4286 (2003). https://doi.org/10.1038/sj.onc.1206621

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206621

Keywords

This article is cited by

Search

Quick links